Senestech Inc Stock Price, News & Analysis

SenesTech (NASDAQ: SNES) announced the Town of Swampscott launched a pilot deploying Evolve® Rat Birth Control at the Swampscott Firehouse and a local school beginning Oct. 13, 2025.

The humane fertility control bait targets rat reproduction rather than using traditional poisons and is described as palatable to rats and safe for non-target species. The pilot runs through the fall with monitoring by city officials, product specialists, Speak Up for Animals, and local advocates; expansion to more neighborhoods in 2026 is possible if results are successful.

SenesTech (NASDAQ: SNES), a leader in fertility control solutions for animal pest populations, has announced its participation in the upcoming Lytham Partners Fall 2025 Investor Conference on September 30, 2025.

The company will deliver a webcast presentation at 2:45 p.m. ET and conduct one-on-one meetings with investors during the virtual event. Investors can access the webcast through the conference website and schedule individual meetings with management through Lytham Partners.

SenesTech (NASDAQ: SNES) announced that its Evolve™ Rat Birth Control product is now available for purchase on HomeDepot.com, marking a significant expansion in consumer accessibility. The product is the first and only soft bait targeting rat reproduction, offering a non-toxic alternative to traditional pest control methods.

The launch on Home Depot's online platform, which processed over 395 million online transactions in 2024, represents a strategic move to reach millions of homeowners through a major retail channel. The product can be shipped nationwide for store pickup or direct delivery to consumers.

SenesTech (NASDAQ: SNES) announced the expansion of its Evolve™ Rat Birth Control solution to Chicago's Old Town Special Service Area #48. The deployment will cover strategic alleyways throughout the SSA, which spans approximately 0.6 square miles and supports over 200 businesses.

The initiative, led by the Old Town Merchants and Residents Association (OTMRA), aims to address rodent control in a sustainable way. Evolve™, classified as a minimum-risk pesticide by the EPA, is designed to reduce fertility in both male and female rats without harming non-target animals, making it ideal for urban environments.

SenesTech (NASDAQ: SNES), a company specializing in fertility control solutions for animal pest populations, has announced its participation in the upcoming Lytham Partners 2025 Consumer & Technology Investor Summit. The virtual presentation is scheduled for Tuesday, August 19, 2025, at 3:30 p.m. ET.

Investors can access the webcast through the conference homepage or directly via the company-specific link, with replay options available afterward.

SenesTech (NASDAQ: SNES), the manufacturer of EPA-registered rodent birth control products, reported strong Q2 2025 financial results. The company achieved record revenue of $625,000, up 36% year-over-year, with Evolve™ Rodent Birth Control products growing 94% and representing 83% of total revenue.

Key highlights include record gross profit margin of 65.4%, improved from 54.2% in Q2 2024, and a net loss of $1.6 million. The company maintains a strong cash position of $11.2 million as of August 5, 2025, providing runway through 2027. SenesTech expanded its municipal pilot deployments across major U.S. cities and completed a move to a new automated manufacturing facility in July 2025.

SenesTech (NASDAQ: SNES), a fertility control solutions provider for animal pest populations, has closed a warrant exercise transaction generating $6.3 million in gross proceeds. The transaction involved the exercise of existing warrants for 1,458,872 shares at $4.15 per share, with H.C. Wainwright acting as exclusive placement agent.

As part of the deal, SenesTech issued new unregistered short-term warrants to purchase 2,188,308 shares at $5.25 per share, with a purchase price of $0.125 per warrant. These new warrants, if fully exercised, could generate additional proceeds of $11.5 million. The company plans to use the net proceeds for working capital and general corporate purposes.

SenesTech (NASDAQ: SNES), a fertility control solutions provider for animal pest populations, has announced warrant exercise agreements that will generate $6.3 million in gross proceeds. The transaction involves the immediate exercise of existing warrants to purchase 1,458,872 shares at $4.15 per share.

As part of the deal, the company will issue new unregistered short-term warrants for 2,188,308 shares at an exercise price of $5.25 per share, with a purchase price of $0.125 per warrant. These new warrants will expire 15 months after the effective date of the resale registration statement. If fully exercised, the new warrants could generate additional proceeds of $11.5 million.

SenesTech (NASDAQ: SNES), a fertility control solutions provider for animal pest populations, has scheduled its Second Quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.

The company will host a conference call at 5:00 p.m. Eastern time on the same day to discuss the results. Investors can access the live webcast through the company's Investor Relations website, with a replay available for 90 days following the presentation.